Brief: Eckert & Ziegler and Pentixapharm Sign Manufacturing Agreement Limited To Clinical Development Phase
April 24 (Reuters) - ECKERT & ZIEGLER SE EUZG.DE: SIGNS MANUFACTURING AGREEMENT WITH PENTIXAPHARM AGREEMENT LIMITED TO CLINICAL DEVELOPMENT PHASE Source text: ID:nEQ1Tx56sa Further company coverage: EUZG.DE (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Eckert & Ziegler SE
See all newsBrief: Eckert & Ziegler Brazil And Terthera Sign Supply Agreement For Terbium-161
Germany's Eckert & Ziegler H1 net income rises, confirms FY view
Brief: Eckert & Ziegler - FY Outlook Confirmed
Brief: Eckert & Ziegler: BaFin Questions Pentixapharm Spin-Off Accounting at Eckert & Ziegler
Germany's Eckert & Ziegler Q1 sales rise on medical segment growth